BOOK
Pain Management, An Issue of Anesthesiology Clinics, E-Book
Perry G. Fine | Michael A. Ashburn
(2016)
Additional Information
Book Details
Abstract
This issue of Anesthesiology Clinics focuses on Pain Management.Topics will include: The Pain Treatment Imperative: Developments in the 21st Century, Imaging Pain, The Opioid Conundrum, Advancing the Pain Agenda in the Veteran Population ,Interventional Treatments of Cancer Pain, Integrating Pain Care into the Peri-Operative Surgical Home, Pain Care in the ED, Sleep and Pain, Can Chronic Pain be Prevented?, The Use of Outcome Data to Improve Patient Outcomes, and Impact of State-based Pain Legislation on Patient Outcomes.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Pain Management\r | i | ||
| Copyright\r | ii | ||
| Contributors | iii | ||
| CONSULTING EDITOR | iii | ||
| EDITORS | iii | ||
| AUTHORS | iii | ||
| Contents | vii | ||
| Foreword: Chronic Pain and Its Treatment in an Era of Increased Scrutiny\r | vii | ||
| Preface: Pain Management\r | vii | ||
| Imaging Pain\r | vii | ||
| Advanced Concepts and Controversies in Emergency Department Pain Management\r | vii | ||
| Managing Opioid-Tolerant Patients in the Perioperative Surgical Home\r | vii | ||
| Can Chronic Pain Be Prevented?\r | viii | ||
| Interventional Treatments of Cancer Pain\r | viii | ||
| Chronic Pain and the Opioid Conundrum\r | viii | ||
| Advancing the Pain Agenda in the Veteran Population\r | viii | ||
| Assessing and Managing Sleep Disturbance in Patients with Chronic Pain\r | ix | ||
| Using Chronic Pain Outcomes Data to Improve Outcomes\r | ix | ||
| State Policies Regulating the Practice of Pain Management: Statutes, Rules, and Guidelines That Shape Pain Care\r | ix | ||
| ANESTHESIOLOGY CLINICS\r | x | ||
| FORTHCOMING ISSUES | x | ||
| September 2016 | x | ||
| December 2016 | x | ||
| March 2017 | x | ||
| RECENT ISSUES | x | ||
| March 2016 | x | ||
| December 2015 | x | ||
| September 2015 | x | ||
| Foreword: Chronic Pain and Its Treatment in an Era of Increased Scrutiny\r | xi | ||
| Preface:\rPain Management | xiii | ||
| Imaging Pain | 255 | ||
| Key points | 255 | ||
| INTRODUCTION | 255 | ||
| ANATOMIC AND FUNCTIONAL SUBSTRATES | 256 | ||
| Basic Sequence of Mechanisms and Structures Involved in Pain Processing | 256 | ||
| IMAGING FINDINGS | 258 | ||
| Regional Changes in Brain Structure | 258 | ||
| Regional Changes in Brain Function | 259 | ||
| Network-Based Changes in Brain Function | 260 | ||
| Multivariate Analysis of Neuroimaging Data | 261 | ||
| Longitudinal Limitations of Chronic Pain Neuroimaging Research | 261 | ||
| SUMMARY | 263 | ||
| ACKNOWLEDGMENTS | 263 | ||
| REFERENCES | 263 | ||
| Advanced Concepts and Controversies in Emergency Department Pain Management | 271 | ||
| Key points | 271 | ||
| INTRODUCTION | 271 | ||
| Acute Pain | 272 | ||
| Opioids | 272 | ||
| Parenteral (intravenous) dosing | 272 | ||
| Nebulized/intranasal analgesia | 273 | ||
| Patient-controlled analgesia | 273 | ||
| Nonsteroidal Antiinflammatory Drugs | 274 | ||
| Acetaminophen | 274 | ||
| Ketamine | 275 | ||
| Local Anesthetics | 275 | ||
| Topical | 275 | ||
| Regional (ultrasound-guided nerve blocks) | 275 | ||
| Intra-articular | 276 | ||
| Systemic (intravenous) | 276 | ||
| Nitrous Oxide | 276 | ||
| Channels/enzymes/receptors Targeted Analgesia Concept | 276 | ||
| CHRONIC PAIN | 277 | ||
| SUMMARY | 280 | ||
| REFERENCES | 281 | ||
| Managing Opioid-Tolerant Patients in the Perioperative Surgical Home | 287 | ||
| Key points | 287 | ||
| INTRODUCTION | 287 | ||
| The Perioperative Surgical Home | 288 | ||
| Opioids | 288 | ||
| Opioid Tolerance | 289 | ||
| Opioid-Induced Hyperalgesia | 289 | ||
| PREOPERATIVE ASSESSMENT | 289 | ||
| Opioid Agonists | 291 | ||
| INTRAOPERATIVE MANAGEMENT | 292 | ||
| Ketamine | 292 | ||
| Regional Anesthesia and Analgesia | 293 | ||
| Lidocaine Infusions | 293 | ||
| Dexmedetomidine | 294 | ||
| POSTOPERATIVE MANAGEMENT | 294 | ||
| Multimodal Approach to Postoperative Analgesia | 294 | ||
| Postoperative Oral Analgesics and Restarting Home Medications | 295 | ||
| SPECIAL CONSIDERATIONS: OPIOID ADDICTION THERAPY | 295 | ||
| Buprenorphine | 296 | ||
| Naltrexone | 297 | ||
| Acute Pain Management Services in the Perioperative Surgical Home | 297 | ||
| SUMMARY | 298 | ||
| REFERENCES | 298 | ||
| Can Chronic Pain Be Prevented? | 303 | ||
| Key points | 303 | ||
| INTRODUCTION | 303 | ||
| COMMON SURGICAL PROCEDURES ASSOCIATED WITH PERSISTENT POSTSURGICAL PAIN | 304 | ||
| Persistent Pain After Breast Surgery | 304 | ||
| Thoracic Surgery | 304 | ||
| Postamputation Phantom Limb Pain | 305 | ||
| MECHANISMS FOR THE DEVELOPMENT OF PERSISTENT POSTSURGICAL PAIN | 305 | ||
| GENETICS/EPIGENETICS OF PERSISTENT POSTSURGICAL PAIN | 306 | ||
| RISK FACTORS FOR THE DEVELOPMENT OF CHRONIC PAIN AFTER SURGERY | 307 | ||
| ANALGESIA FOR PREVENTION OF CHRONIC PAIN | 309 | ||
| Nonsteroidal Anti-inflammatory Drugs | 309 | ||
| Gabapentin | 309 | ||
| Pregabalin | 310 | ||
| Ketamine | 310 | ||
| Regional Anesthesia/Neuroaxial Anesthesia | 310 | ||
| Multimodal Analgesia | 311 | ||
| SUMMARY | 311 | ||
| REFERENCES | 312 | ||
| Interventional Treatments of Cancer Pain | 317 | ||
| Key points | 317 | ||
| INTRODUCTION | 317 | ||
| INTRATHECAL DRUG DELIVERY | 318 | ||
| Indications | 318 | ||
| Pharmacologic Options | 318 | ||
| Methods of Intrathecal Drug Delivery | 318 | ||
| Percutaneous catheter | 318 | ||
| Implanted drug delivery systems | 318 | ||
| Complications of Intrathecal Drug Delivery | 320 | ||
| Efficacy of Intrathecal Drug Delivery for Cancer Pain | 320 | ||
| Intrathecal Drug Delivery and Ongoing Oncologic Care | 322 | ||
| VERTEBRAL AUGMENTATION | 322 | ||
| Indications | 324 | ||
| Contraindications | 324 | ||
| Complications | 324 | ||
| Outcomes | 324 | ||
| NEUROLYTIC PLEXUS BLOCKS | 324 | ||
| Celiac Plexus Neurolysis | 326 | ||
| Indications | 327 | ||
| Contraindications | 327 | ||
| Complications | 327 | ||
| Outcomes | 328 | ||
| Superior Hypogastric Plexus Neurolysis | 328 | ||
| Indications | 329 | ||
| Contraindications | 329 | ||
| Complications | 329 | ||
| Outcomes | 329 | ||
| Ganglion Impar Neurolysis | 330 | ||
| Indications | 330 | ||
| Contraindications | 330 | ||
| Complications | 330 | ||
| Outcomes | 330 | ||
| Peripheral Nerve Neurolytic Blockade | 331 | ||
| Intercostal Neurolysis | 331 | ||
| Indications | 332 | ||
| Contraindications | 332 | ||
| Complications | 332 | ||
| Outcomes | 332 | ||
| Trigeminal Neurolysis | 332 | ||
| Indications | 334 | ||
| Contraindications | 334 | ||
| Complications | 334 | ||
| Outcomes | 334 | ||
| Neurolytic Blocks of the Extremities | 334 | ||
| IMAGE-GUIDED PERCUTANEOUS TUMOR ABLATION | 334 | ||
| Radiofrequency Ablation | 334 | ||
| Cryoablation | 334 | ||
| Indications | 335 | ||
| Contraindications | 335 | ||
| Complications | 335 | ||
| Outcomes | 335 | ||
| Radiofrequency ablation | 335 | ||
| Cryoablation | 335 | ||
| OTHER INTERVENTIONAL TREATMENTS OF CANCER PAIN | 336 | ||
| Spinal Cord Stimulation | 336 | ||
| Intrathecal Neurolysis | 336 | ||
| Neurosurgical Procedures | 336 | ||
| SUMMARY | 336 | ||
| REFERENCES | 336 | ||
| Chronic Pain and the Opioid Conundrum | 341 | ||
| Key points | 341 | ||
| INTRODUCTION | 341 | ||
| LESSONS LEARNED FROM HISTORY | 341 | ||
| Brief Background on Chronic Pain | 342 | ||
| Brief Background on Opioid-Related Death, Misuse, Abuse, Addiction | 343 | ||
| OPIOID EFFECTIVENESS DATA | 344 | ||
| ABUSE-DETERRENT TECHNOLOGY | 346 | ||
| THE PROBLEM WITH PAYER POLICIES | 346 | ||
| OPIOID RESEARCH STILL NEEDED | 346 | ||
| REGULATORY CONSIDERATIONS | 347 | ||
| Upper Dose Limits: Washington State | 347 | ||
| Risk Evaluation and Mitigation Strategy Programs | 347 | ||
| Food and Drug Administration Labeling Changes | 348 | ||
| Rescheduling of Hydrocodone | 348 | ||
| PRINCIPLES OF PRACTICE | 348 | ||
| Opioid Guidelines from Professional Medical Societies | 348 | ||
| Health Care Providers Are Not Alone | 350 | ||
| SUMMARY | 350 | ||
| ACKNOWLEDGMENTS | 351 | ||
| REFERENCES | 351 | ||
| Advancing the Pain Agenda in the Veteran Population | 357 | ||
| Key points | 357 | ||
| INTRODUCTION: PAIN, A PUBLIC HEALTH PROBLEM | 357 | ||
| PAIN IN MILITARY PERSONNEL AND IN VETERANS | 359 | ||
| THE PREVENTION AND REVERSAL OF PAIN CHRONIFICATION | 360 | ||
| Primary Prevention | 360 | ||
| Secondary Prevention | 361 | ||
| Tertiary Prevention | 361 | ||
| STRUCTURAL CHALLENGES | 362 | ||
| THE STEPPED-CARE APPROACH | 365 | ||
| PROVIDING EDUCATION AND TRAINING | 368 | ||
| VETERANS HEALTH ADMINISTRATION PAIN RESEARCH | 372 | ||
| SUMMARY | 372 | ||
| ACKNOWLEDGMENTS | 372 | ||
| REFERENCES | 373 | ||
| Assessing and Managing Sleep Disturbance in Patients with Chronic Pain | 379 | ||
| Key points | 379 | ||
| INTRODUCTION | 380 | ||
| ASSESSMENT OF SLEEP DISTURBANCE | 381 | ||
| NONPHARMACOLOGIC INTERVENTIONS | 382 | ||
| Cognitive Behavior Therapy for Pain and Sleep | 382 | ||
| Cognitive behavior therapy for pain | 382 | ||
| Cognitive behavior therapy for insomnia | 382 | ||
| Combined treatment of pain and sleep | 383 | ||
| PHARMACOTHERAPY | 383 | ||
| Opioid Analgesics | 383 | ||
| Benzodiazepine Receptor Agonists | 385 | ||
| Nonbenzodiazepine Benzodiazepine Receptor Agonists | 386 | ||
| Antidepressants | 386 | ||
| Antipsychotics | 388 | ||
| Anticonvulsants | 388 | ||
| Over-the-Counter Medications | 388 | ||
| SUMMARY | 389 | ||
| REFERENCES | 389 | ||
| Using Chronic Pain Outcomes Data to Improve Outcomes | 395 | ||
| Key points | 395 | ||
| INTRODUCTION | 395 | ||
| HEALTH CARE ECONOMICS | 396 | ||
| UTILIZING DATA TO IMPROVE EFFICIENCY AND QUALITY | 397 | ||
| BEGINNINGS OF TRACKING PAIN OUTCOMES ON A NATIONAL LEVEL | 397 | ||
| THE AFFORDABLE CARE ACT | 398 | ||
| Bundled Payment for Care Improvement Initiative | 398 | ||
| Chronic Care Management Services | 399 | ||
| CENTERS FOR MEDICARE & MEDICAID SERVICES OUTCOMES AND OPIOID PRESCRIPTION PROGRAMS | 399 | ||
| PATIENT-REPORTED OUTCOME MEASURES | 401 | ||
| TRI-INSTITUTIONAL PAIN REGISTRY | 401 | ||
| Data Collection and Storage | 402 | ||
| Merging Patient Data from Different Electronic Systems | 404 | ||
| Data Analysis and Dissemination | 404 | ||
| INTEGRATION INTO ELECTRONIC HEALTH RECORDS | 404 | ||
| INTEGRATING MOBILE TECHNOLOGY | 405 | ||
| SUMMARY | 406 | ||
| REFERENCES | 406 | ||
| State Policies Regulating the Practice of Pain Management | 409 | ||
| Key points | 409 | ||
| INTRODUCTION | 409 | ||
| Influence of Authoritative Model Policy Templates | 410 | ||
| Guidelines Originating in State Agencies | 412 | ||
| METHODOLOGY | 413 | ||
| Policy Collection | 413 | ||
| Policy Evaluation | 413 | ||
| RESULTS | 414 | ||
| Statements Acknowledging or Encouraging Use of Alternatives to Opioids | 414 | ||
| Evaluation Requirements | 415 | ||
| Urine Drug Testing | 415 | ||
| Consultation with Other Clinicians | 415 | ||
| Periodic Review | 418 | ||
| Informed Consent | 418 | ||
| Treatment Agreements | 419 | ||
| Qualifications of Physicians | 419 | ||
| Threshold Doses and Durations | 420 | ||
| DISCUSSION | 422 | ||
| ACKNOWLEDGMENTS | 422 | ||
| REFERENCES | 422 | ||
| Index | 425 |